• norsk
    • English
  • norsk 
    • norsk
    • English
  • Logg inn
Vis innførsel 
  •   Hjem
  • Handelshøyskolen BI
  • Student papers
  • Master of Science
  • Vis innførsel
  •   Hjem
  • Handelshøyskolen BI
  • Student papers
  • Master of Science
  • Vis innførsel
JavaScript is disabled for your browser. Some features of this site may not work without it.

Corporate diversification strategies and their effects on firm performance - the case of Samsung's venture into healthcare

Maier, Michl Sebastian
Master thesis
Thumbnail
Åpne
1775075.pdf (4.241Mb)
Preliminary Master Thesis Report.pdf (1.828Mb)
Permanent lenke
http://hdl.handle.net/11250/2478320
Utgivelsesdato
2017
Metadata
Vis full innførsel
Samlinger
  • Master of Science [1823]
Sammendrag
The question of how and why firms diversify has been a focal point of strategy

research for several decades. However, results have been contradictory, especially

in regard to the diversification-performance dichotomy. While there is a certain

acceptance for the curvilinear relationship between the degree of relatedness of

the target industry and firm performance i.e. performance increases in

(constrained) related cases, and decreases with decreasing levels of relatedness,

some studies have found reverse effects. This thesis investigates the nature of

unrelated diversification through a case study on Samsung’s venture into

healthcare. By comparing Samsung’s recent diversification into the medical

device and biosimilar industries in terms of industry relatedness, market entry

strategies, and firm performance, the thesis will present a case in which the

unrelated diversification target (biosimilars) is outperforming the (constrained)

related one (medical devices). As such, this thesis will present an alternative to the

established theory on corporate diversification strategies. Based on a combination

of the external, internal, and financial perspectives of diversification theory, this

thesis finds that the case of Samsung’s venture into healthcare contradicts several

prior findings from the external and internal perspectives, while confirming most

of the theories from the financial perspective. As diversification research has

historically been grouped into studies on firms from developed and emerging

markets respectively, the case of Samsung presents the opportunity to analyze a

conglomerate that has developed in the context of an emerging economy, which is

currently transitioning quickly towards a developed country. As such, Samsung

needs to adapt its approach to conducting business in globalized and hyper

competitive markets.

Keywords: Corporate diversification strategies; firm performance; related and

unrelated diversification, Samsung, healthcare.
Beskrivelse
Masteroppgave(MSc) in Master of Science in Business, International business - Handelshøyskolen BI, 2017
Utgiver
BI Norwegian Business School

Kontakt oss | Gi tilbakemelding

Personvernerklæring
DSpace software copyright © 2002-2019  DuraSpace

Levert av  Unit
 

 

Bla i

Hele arkivetDelarkiv og samlingerUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifterDenne samlingenUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifter

Min side

Logg inn

Statistikk

Besøksstatistikk

Kontakt oss | Gi tilbakemelding

Personvernerklæring
DSpace software copyright © 2002-2019  DuraSpace

Levert av  Unit